Evergreen guide · Practical foundations

10 things you can do for a longer, healthier life

What human evidence actually supports—and where the longevity claims get ahead of the science.

This is a reading order, not a score or efficacy ranking. The sections are not interchangeable prescriptions. Eligibility, risks and treatment choices belong in an individual clinical conversation.

Ten sturdy foundation stones supporting an open path while shiny shortcuts remain off to one side.
Editorial illustration. Foundations come before shortcuts. This image is not scientific evidence and does not depict guaranteed lifespan extension. Credit: MoreYears.news editorial · original AI-assisted illustration.
  1. Observational evidence

    Don’t smoke—and quit if you do.

    What the evidence shows

    Two large linked-cohort analyses found roughly threefold higher mortality with current cigarette smoking and lower excess mortality after stopping. Earlier cessation was associated with larger population survival gains.

    What it does not prove

    The cohorts do not promise anyone a particular number of years, compare quitting products, or turn a population model into an individual forecast.

    Read the smoking and mortality evidence →

  2. Function

    Keep moving—and protect strength and mobility as you age.

    What the evidence shows

    Published trials support mobility and physical function in defined populations. Supervised resistance training and tailored programs answer narrower questions about strength, bone and falls.

    What it does not prove

    No one program has proved that it slows biological aging, prevents every fall, or extends every participant’s life.

    Exercise and healthy agingLate-life mobilitySupervised resistance training

  3. Clinical outcomes

    Know and manage your blood pressure.

    What the evidence shows

    SPRINT found fewer cardiovascular events and deaths with its intensive strategy in eligible high-risk adults without diabetes, while adverse-event tradeoffs remained visible.

    What it does not prove

    SPRINT does not set one universal target or treatment plan for every person.

    Read the SPRINT evidence →

  4. Risk-factor evidence

    Protect metabolic health and reduce diabetes risk.

    What the evidence shows

    DPP/DPPOS measured diabetes incidence and microvascular outcomes; Look AHEAD measured weight, risk factors and cardiovascular events; SELECT tested cardiovascular outcomes in a defined population.

    What it does not prove

    Weight change, diabetes prevention and cardiovascular events are not interchangeable with slower aging or guaranteed longevity.

    DPP/DPPOSLook AHEADGLP-1 evidence

  5. Clinical outcomes

    Favor an eating pattern with clinical-outcome evidence—not a longevity fad diet.

    What the evidence shows

    PREDIMED reported cardiovascular outcomes, with its correction history attached. CALERIE and time-restricted-eating trials measured shorter-term metabolic, risk-factor and biomarker outcomes.

    What it does not prove

    The calorie-restriction and eating-window studies did not demonstrate extra human lifespan, and PREDIMED does not make one menu universal.

    Mediterranean dietCALERIEEating windows

  6. Function

    Protect sleep—and treat real sleep problems rather than chasing “sleep optimization.”

    What the evidence shows

    Sleep-duration and regularity studies are observational. CBT-I trials address insomnia outcomes. CPAP trials distinguish symptoms and quality of life from cardiovascular events.

    What it does not prove

    Observational sleep patterns do not establish a causal longevity formula, and treating one sleep problem does not guarantee cardiovascular or lifespan benefit.

    Sleep and healthy agingCBT-ICPAP outcomes

  7. Clinical outcomes

    Stay current on vaccines appropriate for age and risk.

    What the evidence shows

    These vaccine studies lead with prevention of shingles, influenza or RSV disease in their tested populations. A shingles rollout also created observational dementia evidence worth studying.

    What it does not prove

    Vaccination is not “immune rejuvenation,” and the shingles analysis does not turn a vaccine into a proven dementia treatment.

    Shingles vaccineHigh-dose flu vaccineRSV vaccines

  8. Clinical outcomes

    Use cancer screening where the evidence and individual risk make sense.

    What the evidence shows

    NLST, NordICC and ERSPC measured different cancer diagnoses, cancer-specific deaths and all-cause mortality in defined eligible populations, with participation and harms attached.

    What it does not prove

    These trials do not support a blanket instruction to obtain every test. False positives, overdiagnosis, eligibility and individual risk remain part of the decision.

    Lung screeningColonoscopyPSA tradeoffs

  9. Function

    Protect bones, balance, and independence.

    What the evidence shows

    Fracture, mobility, serious injury, self-reported falls and fall incidence are distinct outcomes. Zoledronic acid, LIFE, STRIDE, LiFE and tailored Tai Ji Quan each answer a defined question.

    What it does not prove

    A change in falls, bone density or a functional test is not automatically permanent independence, healthspan or lifespan.

    FracturesMobilityTailored Tai Ji Quan

  10. Evidence boundary

    Don’t let “anti-aging” pills and hacks crowd out the boring things that work.

    What the evidence shows

    Large trials can overturn plausible prevention ideas. Smaller supplement studies may establish target engagement, feasibility or short-term signals without demonstrating longer healthy life.

    What it does not prove

    A biomarker shift, small pilot or animal mechanism is not evidence that a pill or hack adds healthy human years.

    ASPREENAD precursorsResveratrol

What isn’t on our Top 10

Popular ideas can be worth researching without belonging among the foundations. Sauna and cold exposure currently lean on observational or short-term evidence; hyperbaric oxygen reports biomarkers in small studies; rapamycin, NAD precursors, resveratrol, spermidine and GlyNAC remain limited by small trials, surrogate outcomes, null primary results, product specificity or other boundaries. Promising biology is not the same as demonstrated extra healthy years.

How this guide was assembled

The nine established sections summarize only conclusions already released through the MoreYears evidence workflow. The smoking section relies on a new three-pass evidence review and frozen claim map. The ordering is editorial, not quantitative. No pooled longevity estimate, dosage, personal target, screening schedule, vaccine schedule or individualized treatment plan was created.

AI disclosure: AI-assisted research and drafting were used after the smoking evidence map was frozen. Editors traced every medical statement to governed MoreYears coverage or the new smoking claim map. This guide is educational and not medical advice.